Pharma Journalist - Page 3 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

uniQure Reports Early Promise for Epilepsy Gene Therapy

Boltz and Takeda Expand AI-Powered Drug Discovery Efforts

SK Pharmteco Partners With OTXL for Rare Disease Therapies

Next-Generation GLP-1 Therapies Are Reshaping the Future of Obesity Treatment

AI-Designed Drug Candidates Enter Clinical Trials: A New Era for Drug Discovery

Vedana Launches With $46 Million for Migraine Therapies

LG AI and D&D Pharmatech Join Forces on Oral Peptides

Jazz and AbCellera Partner on Cancer Antibody Therapies

Biogen to Acquire RayThera in $1 Billion Deal

Insilico Reaches Clinical Milestone for AI-Designed NLRP3 Inhibitor